Synonym
ZPL-3893787; ZPL3893787; ZPL 3893787; ZPL-389; ZPL 389; ZPL389; PF-03893787; PF03893787; PF 03893787; PF-3893787; PF3893787; PF 3893787; Adriforant;
IUPAC/Chemical Name
(R)-N4-(cyclopropylmethyl)-6-(3-(methylamino)pyrrolidin-1-yl)pyrimidine-2,4-diamine
InChi Key
ISBHYKVAFKTATD-SNVBAGLBSA-N
InChi Code
InChI=1S/C13H22N6/c1-15-10-4-5-19(8-10)12-6-11(17-13(14)18-12)16-7-9-2-3-9/h6,9-10,15H,2-5,7-8H2,1H3,(H3,14,16,17,18)/t10-/m1/s1
SMILES Code
NC1=NC(N2CC[C@@H](NC)C2)=CC(NCC3CC3)=N1
Appearance
White to off-white solid powder.
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
262.36
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Andaloussi M, Lim HD, van der Meer T, Sijm M, Poulie CB, de Esch IJ, Leurs R,
Smits RA. A novel series of histamine H4 receptor antagonists based on the
pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence
time with PF-3893787. Bioorg Med Chem Lett. 2013 May 1;23(9):2663-70. doi:
10.1016/j.bmcl.2013.02.091. Epub 2013 Mar 1. PubMed PMID: 23558237.
2: Salcedo C, Pontes C, Merlos M. Is the H4 receptor a new drug target for
allergies and asthma? Front Biosci (Elite Ed). 2013 Jan 1;5:178-87. Review.
PubMed PMID: 23276980.
3: Mowbray CE, Bell AS, Clarke NP, Collins M, Jones RM, Lane CA, Liu WL, Newman
SD, Paradowski M, Schenck EJ, Selby MD, Swain NA, Williams DH. Challenges of drug
discovery in novel target space. The discovery and evaluation of PF-3893787: a
novel histamine H4 receptor antagonist. Bioorg Med Chem Lett. 2011 Nov
1;21(21):6596-602. doi: 10.1016/j.bmcl.2011.07.125. Epub 2011 Aug 9. PubMed PMID:
21920751.